Adjuvance Technologies
New York, US
Biotech
Founders & leadership
CF
Christopher FrigonExecutive Officer
JG
Jeffrey GardnerExecutive Officer
MG
Mary GinDirector
GP
Gregory PolandDirector
TM
Tyler MartinExecutive Officer, Director
PL
Phil LivingstonDirector
JG
John GalloDirector
Reported raises · per SEC filings
Form D private placements$10.7MraisedNov 2019 · 28 investors · Biotechnology
Rule 506(b)$2.7MraisedNov 2016 · 15 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.